Archive NCI Notices:  FY 2024  FY 2023  FY 2022  FY 2021  FY 2020  FY 2019  FY 2018 | Active Notices | Recently Cleared Concepts | Notices | NCI Grant Policies
Archive NCI and Trans-NIH Initiatives (U01)
Initiatives that have expired (and associated notices)
 
2024 Archive  Requests for Applications (RFA's)
RFA No. and Title Status - Expiration
CA24-005 Cancer Prevention, Detection, Diagnosis, and Treatment Technologies for Global Health (U01 Clinical Trial Optional)EXPIRED - OCT 14, 2023
 
2024 Archive  Trans-NIH Requests for Applications (RFA's)
RFA No. and Title Status - Expiration
HD24-011 HEAL Initiative: HEAL KIDS (Knowledge, Innovation and Discovery Studies) Pain: Acute Pain Clinical Trials Program (U01 Clinical Trial Required)EXPIRED - NOV 21, 2023
 
 
 
 
 
2023 Archive  Requests for Applications (RFA's)
RFA No. and Title Status - Expiration
CA23-040 Pre-Cancer Atlas (PCA) Research Centers (U01 Clinical Trial Not Allowed)EXPIRED - DEC 06, 2023
CA23-039 Human Tumor Atlas (HTA) Research Centers (U01 Clinical Trial Not Allowed)EXPIRED - DEC 06, 2023
CA23-036 Mechanisms of Fusion-Driven Oncogenesis in Childhood Cancers (U01 Clinical Trial Not Allowed)EXPIRED - NOV 16, 2023
CA23-033 Implementation Science for Cancer Control in People Living with HIV in Low- and Middle-Income Countries (U01 Clinical Trial Optional)EXPIRED - DEC 16, 2023
CA23-025 Addressing the Primary Care Needs of Cancer Survivors (U01 Clinical Trial Required)EXPIRED - JUL 01, 2023
CA23-023 Liver Cancer Collaborative Projects with the Liver Cirrhosis Network (U01 Clinical Trial Optional)EXPIRED - JUN 03, 2023
CA23-018 Precompetitive Collaboration on Liquid Biopsy for Early Cancer Assessment: Liquid Biopsy Research Laboratories (U01 Clinical Trial Not Allowed)EXPIRED - JAN 11, 2023
CA23-015 Early-Stage Development of Informatics Technologies for Cancer Research and Management (U01 Clinical Trial Optional)EXPIRED - NOV 18, 2023
CA23-007 Revision Applications for Incorporation of Novel NCI- Supported Technology to Accelerate Cancer Research (U01 Clinical Trial Optional)EXPIRED - SEP 02, 2023
 
2023 Archive  Trans-NIH Requests for Applications (RFA's)
RFA No. and Title Status - Expiration
DE23-013 AHEAD (Advancing Head and Neck Cancer Early Detection Research) (U01 Clinical Trial Not Allowed)EXPIRED - MAR 15, 2023
OD23-021 Public Health Communication Messaging about the Continuum of Risk for Tobacco Products (U01 Clinical Trial Required)EXPIRED - DEC 07, 2023
 
2023 Archive  Trans-NIH Program Announcements (PAs)
PA No. and Title Status - Expiration
PAR23-203 Limited Competition: Collaborative Partnership to Advance Global Health Research (U01 Clinical Trial Not Allowed)EXPIRED - SEP 02, 2023
PAR23-182 Accelerating Behavioral and Social Science through Ontology Development and Use: Research Network Projects (U01 Clinical Trial Not Allowed)EXPIRED - OCT 04, 2023
 
 
 
 
 
2022 Archive  Requests for Applications (RFA's)
RFA No. and Title Status - Expiration
CA22-054 The Early Detection Research Network: Clinical Validation Centers (U01 Clinical Trial Optional)EXPIRED - SEP 20, 2022
CA22-052 Cannabis and Cannabinoid Use in Adult Cancer Patients During Treatment: Assessing Benefits and Harms (U01 Clinical Trial Not Allowed)EXPIRED - FEB 18, 2023
CA22-039 The Early Detection Research Network: Clinical Validation Centers (U01 Clinical Trial Optional)EXPIRED - SEP 09, 2022
CA22-031 Consortium on Translational Research in Early Detection of Liver Cancer: Translational Research Centers (U01 Clinical Trial Optional)EXPIRED - NOV 08, 2022
CA22-022 Early-Stage Development of Informatics Technologies for Cancer Research and Management (U01 Clinical Trial Optional)EXPIRED - NOV 18, 2022
CA22-020 Cancer Prevention, Detection, Diagnosis, and Treatment Technologies for Global Health (U01 Clinical Trial Optional)EXPIRED - JUN 18, 2022
CA22-016 Pediatric Immunotherapy Network (PIN) (U01 Clinical Trial Optional)EXPIRED - SEP 28, 2022
CA22-006 Revision Applications for Incorporation of Novel NCI- Supported Technology to Accelerate Cancer Research (U01 Clinical Trial Optional)EXPIRED - SEP 23, 2022
 
2022 Archive  Trans-NIH Requests for Applications (RFA's)
RFA No. and Title Status - Expiration
HG22-010 Multi-Omics for Health and Disease - Data Analysis and Coordination Center (U01 Clinical Trial Not Allowed)EXPIRED - NOV 19, 2022
HG22-009 Multi-Omics for Health and Disease - 'Omics Production Centers (U01 Clinical Trial Not Allowed)EXPIRED - NOV 19, 2022
HG22-008 Multi-Omics for Health and Disease - Disease Study Sites (U01 Clinical Trial Optional)EXPIRED - NOV 19, 2022
OD22-006 Emergency Award: RADx-UP Community-Engaged Research on Rapid SARS-CoV-2 Testing among Underserved and Vulnerable Populations (U01 Clinical Trial Optional)EXPIRED - MAY 03, 2022
OD22-005 Emergency Awards: RADx-UP - Social, Ethical, and Behavioral Implications (SEBI) Research on Disparities in COVID-19 Testing among Underserved and Vulnerable Populations (U01 Clinical Trial Optional)EXPIRED - MAY 03, 2022
OD22-002 Center for Rapid Surveillance of Tobacco (CRST) to Assess Changes in Use Behaviors, Product Marketing, and the Marketplace (U01 Clinical Trial Not Allowed)EXPIRED - MAY 19, 2022
 
 
 
 
 
2021 Archive  Requests for Applications (RFA's)
RFA No. and Title Status - Expiration
CA21-063 A Multilevel Approach to Connecting Underrepresented Populations to Clinical Trials (CUSP2CT; U01 Clinical Trial Optional)EXPIRED - DEC 11, 2021
CA21-057 A Multilevel Approach to Connecting Underrepresented Populations to Clinical Trials (CUSP2CT U01 Clinical Trial Not Allowed)EXPIRED - NOV 20, 2021
CA21-056 Implementation Science for Cancer Control in People Living with HIV in Low- and Middle-Income Countries (U01 Clinical Trial Optional)EXPIRED - DEC 16, 2021
CA21-050 Canine Cancer Immunotherapy Network (K9CIN; U01 Clinical Trial Not Allowed)EXPIRED - SEP 28, 2021
CA21-041 Pancreatic Ductal Adenocarcinoma (PDAC) Stromal Reprogramming Consortium (PSRC) (U01 Clinical Trial Not Allowed)EXPIRED - NOV 02, 2021
CA21-033 The Early Detection Research Network: Clinical Validation Centers (U01 Clinical Trial Optional)EXPIRED - SEP 10, 2021
CA21-031 Exercise and Nutrition Interventions to Improve Cancer Treatment-Related Outcomes (ENICTO) in Cancer Survivors Consortium (U01 Clinical Trial Required)EXPIRED - JUL 15, 2021
CA21-030 Cancer Prevention, Detection, Diagnosis, and Treatment Technologies for Global Health (U01 Clinical Trial Optional)EXPIRED - JUN 03, 2021
CA21-025 Proteogenomic Translational Research Centers (PTRCs) for Clinical Proteomic Tumor Analysis Consortium (U01 Clinical Trial Not Allowed)EXPIRED - JUL 31, 2021
CA21-021 Metabolic Dysregulation and Cancer Risk Program, Research Grants: a Transdisciplinary Approach to Obesity-Associated Research (U01 Clinical Trial Optional)EXPIRED - OCT 07, 2021
CA21-018 Revision Applications to Support the Application of Informatics Technology for Cancer Research (U01 Clinical Trials Optional)EXPIRED - NOV 18, 2021
CA21-014 Early-Stage Development of Informatics Technologies for Cancer Research and Management (U01 Clinical Trial Optional)EXPIRED - NOV 18, 2021
CA21-008 Revision Applications for Incorporation of Novel NCI- Supported Technology to Accelerate Cancer Research (U01 Clinical Trial Optional)EXPIRED - SEP 30, 2021
 
2021 Archive  Trans-NIH Requests for Applications (RFA's)
RFA No. and Title Status - Expiration
OD21-009 Emergency Award: RADx-UP - Social, Ethical, and Behavioral Implications (SEBI) Research on Disparities in COVID-19 Testing among Underserved and Vulnerable Populations (U01 Clinical Trials Optional)EXPIRED - JUL 08, 2021
OD21-008 Emergency Awards: Community-engaged COVID-19 Testing Interventions among Underserved and Vulnerable Populations RADx-UP Phase II (U01 Clinical Trial Optional)EXPIRED - JUL 08, 2021
TW21-001 Hubs of Interdisciplinary Research and Training in Global Environmental and Occupational Health (GEOHealth) Research (Collaborative U01 Clinical Trial Optional)EXPIRED - JUL 09, 2021
 
2021 Archive  Program Announcements (PAs)
PA No. and Title Status - Expiration
PAR21-348 The role of Epstein Barr virus (EBV) infection in Non-Hodgkin Lymphoma (NHL) and Hodgkin disease (HD) development with or without an underlying HIV infection (U01 Clinical Trial Optional)EXPIRED - DEC 16, 2023
PAR21-274 Cancer Target Discovery and Development (CTD2) (U01 Clinical Trial Not Allowed)EXPIRED - OCT 07, 2022
 
2021 Archive  Trans-NIH Program Announcements (PAs)
PA No. and Title Status - Expiration
PAR21-343 Opportunities for Collaborative Research at the NIH Clinical Center (U01 Clinical Trial Optional)EXPIRED - APR 19, 2024
 
 
 
 
 
2020 Archive  Program Announcements (PAs)
PA No. and Title Status - Expiration
PAR20-294 Core Infrastructure Support for Cancer Epidemiology Cohorts (U01 Clinical Trial Not Allowed)EXPIRED - NOV 10, 2022
PAR20-170 New Informatics Tools and Methods to Enhance U.S. Cancer Surveillance Research (U01 Clinical Trial Optional)EXPIRED - JUN 07, 2023
 
 
 
 
 
2019 Archive  Requests for Applications (RFA's)
RFA No. and Title Status - Expiration
CA19-050 Revision Applications for Mechanisms of Drug Resistance (U01 Clinical Trials Not Allowed)EXPIRED - JUN 24, 2021
 
2019 Archive  Program Announcements (PAs)
PA No. and Title Status - Expiration
PAR19-361 Small-Cell Lung Cancer (SCLC) Consortium: Therapeutic Development and Mechanisms of Resistance (U01 Clinical Trial Not Allowed)EXPIRED - MAR 12, 2022
PAR19-287 Research Projects in Cancer Systems Biology (U01 Clinical Trial Optional)EXPIRED - NOV 16, 2021
 
2019 Archive  Trans-NIH Program Announcements (PAs)
PA No. and Title Status - Expiration
PAR19-157 Bioengineering Research Partnerships (U01 Clinical Trial Required)EXPIRED - JAN 08, 2022
PAR19-156 Bioengineering Research Partnerships (U01 Clinical Trial Not Allowed)EXPIRED - JAN 08, 2022
 
 
 
 
 
2018 Archive  Program Announcements (PAs)
PA No. and Title Status - Expiration
PAR18-947 Integrating Biospecimen Science Approaches into Clinical Assay Development (U01 Clinical Trial Not Allowed)EXPIRED - JUL 12, 2021
PAR18-913 Utilizing the PLCO Biospecimens Resource to Bridge Gaps in Cancer Etiology and Early Detection Research (U01 Clinical Trial Not Allowed)EXPIRED - AUG 12, 2021